Research services
Cyclotron and Radiopharmaceutical
Manufacturing more than 30 life-saving diagnostic and therapeutic radiopharmaceuticals for better patient care in the field of nuclear medicine across the Kingdom.
Overview
Cyclotron and Radiopharmaceuticals provides on-demand radiopharmaceuticals production for nuclear medicine centres throughout Saudi Arabia. Using three on-site cyclotrons, we manufacture according to international GMP and SFDA standards, ready-to-use patient doses of more than 30 different radiopharmaceuticals to around 50 hospitals throughout Saudi Arabia.
Radiopharmaceutical Manufacturing
We supply a comprehensive range of PET and SPECT radiopharmaceuticals tailored to patients' clinical needs. Our facility produces radioisotopes using cyclotron bombardment, then processes them through automated synthesis, sterile compounding, and rigorous quality control, delivering reliable radioactive medicines when you need them.
Quality Systems
Every product we deliver meets strict quality specifications. Our testing includes radionuclide identification, radiochemical purity analysis, pH verification, sterility checks, and residual solvent quantification. You receive finished products that comply with regulatory standards and are safe for immediate patient use.
Research and Development
We partner with research institutions and clinical programs to develop custom radiotracers for specialised applications in nuclear oncology and precision medicine. Our team synthesizes novel compounds targeting specific biomarkers, validates their performance through preclinical imaging studies, and scales production for clinical trials.
Whether you need F-18 labeled tracers, Ga-68 diagnostics, or Lu-177 therapeutics, our radiopharmaceutical research and development expertise, combined with micro-PET/CT capabilities, support your research from concept through translation to patient care.
Beta Version